Phase II Study of Intra-Peritoneal Hyper-Thermic Chemotherapy as Consolidation Therapy for Advanced Epithelial Ovarian Carcinoma


Phase 2
18 Years
65 Years
Open (Enrolling)
Female
Epithelial Ovarian Carcinoma, Figo Stage IIIC

Thank you

Trial Information

Phase II Study of Intra-Peritoneal Hyper-Thermic Chemotherapy as Consolidation Therapy for Advanced Epithelial Ovarian Carcinoma


Inclusion Criteria:



epithelial ovarian carcinoma previous surgery + 6 cycles platinum based chemotherapy

-

Exclusion Criteria:

- Patients ASA 3 patients with no residual tumor at first operation negative
microscopic second look

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Principal Investigator

Dominique ELIAS, MD, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Gustave Roussy, Cancer Campus, Grand Paris

Authority:

France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)

Study ID:

CHIPOVAC1

NCT ID:

NCT00349505

Start Date:

September 2004

Completion Date:

Related Keywords:

  • Epithelial Ovarian Carcinoma
  • Figo Stage IIIC
  • previous treatment surgery + 6 cycles of platinum based chemotherapy
  • Carcinoma
  • Ovarian Neoplasms
  • Neoplasms, Glandular and Epithelial

Name

Location